Donors

“This endowed project is unique. Almost all psychedelic research is focused on medical therapeutics in patients. While we can expect this therapeutic research to continue to grow, fueled by increasing commercial and NIH funding, there is virtually no support for what I believe to be the most consequential direction for future psychedelic research, namely the impact of psychedelic substances on broadly defined spirituality and well-being in healthy volunteers. In stark contrast to therapeutic research, the endowed research program is entirely dependent on philanthropic support.”

— Roland R. Griffiths, PhD

Visionary Donors

Alexandra Cohen

Alex is the president of the Steven & Alexandra Cohen Foundation, the nonprofit organization that she and her husband Steve co-founded in 2001. She is the inspiration behind the Foundation, directing its giving toward Lyme and tickborne disease research, mental health, underserved communities, children, the arts, and sustainability. Alex is also the president of the Amazin’ Mets Foundation, which she created in 2020 after she and her husband Steve purchased the New York Mets. Alex was named one of the “50 Most Powerful Women in U.S. Philanthropy” by Inside Philanthropy, serves on the Chairman’s Council of the New York Restoration Project, and on NYU’s Tisch School of the Arts Dean’s Council.

Tim Ferriss

Tim Ferriss has been listed as one of Fast Company’s “Most Innovative Business People” and one of Fortune’s “40 under 40.” He is an early-stage technology investor/advisor (Uber, Facebook, Shopify, Duolingo, Alibaba, and 50+ others) and the author of five #1 New York Times and Wall Street Journal bestsellers, including The 4-Hour Workweek and Tools of Titans: The Tactics, Routines, and Habits of Billionaires, Icons, and World-Class Performers. The Observer and other media have called Tim “the Oprah of audio” due to the influence of The Tim Ferriss Show podcast, which is the first business/interview podcast to exceed 100 million downloads. It has now exceeded 800 million downloads.

Antonio Gracias

Antonio Gracias is President of The Gracias Family Foundation. He is also CEO of Valor Equity Partners, a trustee of The Aspen Institute, a member of the board of visitors of the Georgetown University School of Foreign Service, and a member of the board of visitors of the University of Chicago Law School. Prior to founding Valor, Antonio was the Founder and Managing Member of MG Capital where he acquired and acted as CEO for several manufacturing and technology related companies. Antonio holds a joint B.S. and M.S.F.S. (Honors Degree) in International Finance and Economics from the Georgetown University School of Foreign Service. Antonio also holds a J.D. from the University of Chicago Law School. 

Genevieve Jurvetson

Genevieve is Chair of the Psychedelic Science Funders Collaborative Founders Circle and leads giving for The Jurvetson Family Foundation. Prior to diving into the world of psychedelic science, Genevieve was co-founder and CMO of Fetcher, an AI-powered recruiting startup. Prior to Fetcher, Genevieve ran marketing for Apartment List, the fastest-growing online rental marketplace in the U.S.  She spent the first 8 years of her career in investment banking and investment management, most recently at Goldman Sachs. Genevieve earned a B.S. with Highest Honors from Georgia Tech and an MBA from MIT. Genevieve and her husband Steve live in the Bay Area with their five children.

Steve Jurvetson

Steve Jurvetson is a venture capitalist who has led early investments in several industry redefining companies, representing $800 billion of aggregate value creation.  He has served on the board of directors of Planet, SpaceX and Tesla.  Before co-founding Future Ventures and Draper Fisher Jurvetson (DFJ), Steve was an R&D Engineer at Hewlett-Packard and worked at Apple, NeXT and Bain & Company.  He completed his undergraduate Electrical Engineering degree at Stanford in 2.5 years, graduating #1 in his class, and went on to earn a MSEE and MBA from Stanford. Steve has been honored as one of “Tech’s Best Venture Investors” by Forbes, and as the “Venture Capitalist of the Year” by Deloitte.

Blake Mycoskie

Blake Mycoskie is an entrepreneur and founder of TOMS, the original One for One® business model, which uses business to improve lives by helping people in need with every product purchased. This simple concept has grown into a global movement with TOMS impacting over 100 million lives to date. In fall 2011, Blake released his first book, Start Something That Matters which became a New York Times best-seller. It is Blake’s hope that Start Something That Matters inspires others to turn their passion and dreams into a reality. In 2022, Blake donated a portion of his net worth in support of the Psychedelic Philanthropy space, demonstrating his commitment to helping people.

Carey Turnbull

Carey Turnbull is a serial entrepreneur who founded several financial services companies that were sold to publicly traded Fortune 500 companies. Prior to beginning his business career he lectured about and taught meditation for 10 years. Mr. Turnbull was for 10 years a member of the Executive Committee of the Trustees at Goddard College. He is Chair of the advisory board of the NYU Center for Psychedelic Medicine, and assisted in the founding of Yale University’s psilocybin research program. He is a member of the Board and President of Heffter Research Institute and was a member of the founding Board of Usona Institute. He founded Ceruvia Lifesciences, B.More, and Freedom to Operate.

Claudia Turnbull

Claudia Turnbull has a Master of Arts Degree in Consciousness Studies from Goddard College. She has worked at the Johns Hopkins Center for Psychedelic and Consciousness Research investigating the results of psilocybin experiences had by religious professionals and long term meditators. Claudia  is a founder of B.More, a nonprofit whose mission is to make a prescription medicine of psilocybin for the treatment of substance use disorders, and a founding member of Ceruvia, a corporation whose mission is research and development of neurotransformational medicines. She is a Board member of Heffter Research Institute and a member of the College of the Atlantic Board of Trustees.

Anonymous

Anonymous

Anonymous

Partner Donors

Partner Donor, Kathleen Griffiths Farley

Kathleen Griffiths Farley

Worked for JP Morgan, Citi, and IDS from 1965-1977 and 1984-1987. Non-profit involvement: President and Board member YWCA of Minneapolis, Board member Women Venture, Board member Planned Parenthood, Board member Minneapolis Institute of Arts, Co-chair capital campaigns for YWCA and Abbott Northwestern Hospital Piper Breast Center, President and Board member HOA Cordillera, Colorado.

Ryan Zurrer

Ryan is founder of Dialectic, a family office focused on alternative assets and Vine Ventures, a bio-science venture capital firm focused on neurotech, psychedelics and longevity. He has built a reputation for being a hands-on, value-add venture investor with a uniquely global purview. Previously, he led the Regenerative Financing Vine to support MAPS and he was CEO of a Brazilian renewables firm.

Christiana Musk

Christiana Musk is Chairwoman of Unreasonable Group and host of the BBC podcast Unreasonable Impact: Food Solutions. Her background spans environmental and social entrepreneurship, investment, nonprofit and foundation leadership. She co-founded Zaadz.com and Green Mountain Energy. Her philanthropic work with her husband Kimbal Musk aims to catalyze human and planetary flourishing. 

Waking Up

Waking Up, a meditation and philosophy app created by Sam Harris, gives a minimum of 10% of its profits each year to the most effective charities through the Waking Up Foundation—guided by the belief that, for humanity to flourish, we must work to improve life in the present, while addressing many sources of long-term risk. 

1440 Foundation

The 1440 Foundation, co-created by Joanie and Scott Kriens, serves the vision of Creating Hope for Living Well. To live well requires looking deeply into our lives and stories. We remain forever grateful for Dr. Roland Griffiths, who has modeled for so many the power of commitment, compassion, and curiosity, woven beautifully into a life of gratitude.

Project New Day

Project New Day was Founded to liberate people from their unresolved trauma and related addiction through a revolutionary and scalable open-source program composed of compassionate coaching, clinical psychedelic therapy, and community building. These are the keys to unlocking one’s best life. This is Project New Day.

The Riverstyx Foundation

The Riverstyx Foundation provides funding for stigmatized projects with the greatest potential for compassion and healing. It’s co-directors, Miriam Volat and T. Cody Swift, have thus been honored to support the pioneering research of Roland Griffiths since 2008 – through rigorous science, exploring the deepest questions of consciousness and tools for opening ourselves to the mystery of existence.

Anonymous

Benefactor Donors

Joe & Sandy Samberg

Flourish Impact Fund

Oprah Winfrey Charitable Foundation

Eric and Alia Williams

Supporting Donors

  • George & Requa Greer
  • Peggy Dulany & Barry Walker
  • Luke Nolan
  • Larkin McPhee & Deniz Perese
  • Clinton Blum
  • Mundeep & Priyanka Chaudhry
  • Richard Troxel
  • Jon & Michelle Lawrence
  • Silvia Faidutti
  • Ian Drummond & Gabriel Prada
  • Dan Kerrisk
  • Bessel van der Kolk & Licia Sky
  • Marjorie H. Woollacott
  • Matthew & April Johnson
  • Joshua S. Nunziato
  • William N. Wofford
  • Ted Rebholz
  • Dakota Pfeiffer
  • Michael & Amie Eglit
  • Luis E. Garza
  • Greg & Susan Walker
  • Benjamin Orenstein
  • Stephen Holsenbeck
  • Janis Phelps
  • Duane Schmidt & Christine Dailey 
  • Jesse Starks
  • Jay Hanson
  • Carolyn & Mark Holtzen
  • Susan Fukushima & Richard Cohen
  • Willett Family Foundation
  • Terry Nash
  • Hamilton & Traci Hill
  • Ken Silverman & Ann Apitz
  • Allyn Roberts
  • Matthew & Kristin Dawson
  • Alice Root
  • Karen C. Miller & Graham J Brent
  • Matteo Passamonti
  • Moira Penza & Nathaniel Cullerton
  • Miriam Z. Mintzer
  • Nancy S. Porter & Mary Hey
  • William Courington
  • Matthew R. & Rachel B. Jenkins
  • Jason Wiener
  • Jack E. & Lucy L. Henningfield
  • Alison A. Whitmire
  • Stephen J. Heishman
  • Wayne Silby
  • Debbie L. & Hal Weaver
  • Benjamin Ranck
  • Karen L. Dion
  • Ira Sloan
  • Stephan Westcott
  • Adrian McCann
  • Alex Foster
  • Adele Getty & Michael Williams
  • Jonathan Lowsley
  • Suprotik & Lauren Basu
  • Philip & Carolyn Cunningham
  • Ira & Carole Shadrow
  • Mischa Bauermeister
  • Niel Wyma
  • Andrew Weil
  • Emily & Ryan Foley
  • Shelley S. van Loben Sels-Griffee
  • Elena Aguilar
  • Reed A. & Sheila Morrison
  • James Balls
  • Odette P. & Colin Neal Murphy
  • Silvia Faidutti
  • Jenna & Randall Riemersma
  • Rick M. Hayman
  • Scott S. & Kimberly A Lynch
  • TARA Mind Inc.
  • Bradley E. Whitcomb & Marie Seifert
  • Ferris Follower
  • Duane W. Schmidt & Christine Daily
  • Tim Rossiter
  • Brandon M. Dols
  • Harriet de Wit
  • Wayne Silby
  • Eileen & Paul Growald
  • Dr. Bronner’s
  • Raymond Chang
  • Robert R. Falconer
  • Christina I. Hoffman
  • Roger Jordan
  • Moshe Siev
  • Betsy Jean Brach
  • Mistler-Palomar Philanthropic Fund
  • Alice M. Young
  • Dan Quinn
  • Keith Higginbotham
  • Jessica Rienerth
  • Henry & Ida Makansi
  • Michael Pollan & Judith Belzer
  • Michael P. McDonald
  • Larry Chait & Charmane Eastman
  • Sholom Fishman
  • Patrick C. & Susan Peason
  • Vance Lavizzo
  • Andrew & Miriam Silva Preas
  • Luis E. Garza
  • Marcus Capone & Amber Capone
  • Andrew Stein
  • Robert H. and Marna Lloyde Arthur
  • Glenn B. Wolffe
  • Paul E. Redpath & Sarah V. Baettie
  • Stephen J. Heishman
  • Juan Pablo Capello
  • Michael A. Pollock 
  • Matthew Stodder
  • Ruth & Elliott Joseph
  • Neele Johnston
  • Paul Deverell
  • Noah S. Belkin
  • United Brain Association
  • Carolyn Ferris
  •  Maeve Rockefeller
  • Alison Locker
  • Susan Gauvey
  • Stephen Simon Charitable Fund 
  • John Cammack and Kimberly Warren
  • Brent A. Uhrig

Special thanks to Bob Jesse, whose vision and initiative gave rise to psilocybin research at Johns Hopkins and helped to shape this professorship; to Richard Langer, whose legal acuity and tireless efforts codified the professorship so as to serve its intended purpose in perpetuity; and to Claudia Turnbull, whose leadership brought together the needed funding.

Bob Jesse

Richard Langer

Claudia Turnbull